DEF: QT Imaging Holdings Schedules Annual Meeting, Seeks Shareholder Approval

QT Imaging Holdings, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for July 28, 2026, to elect directors, ratify auditors, and approve an amendment to its equity incentive plan.

Summary

• QT Imaging Holdings, Inc. is holding its Annual Meeting of Stockholders on July 28, 2026, virtually.
• Key proposals include the election of two Class II directors, ratification of BPM LLP as the independent registered public accounting firm for fiscal year 2026, and approval to amend the 2024 Equity Incentive Plan to increase the authorized shares by 550,900.
• The company reported strong revenue growth in 2025, reaching $18.9 million, a 288% increase from $4.9 million in 2024, with 40 QT Breast Acoustic CT Scanners shipped compared to 12 in the prior year.
• Gross margin for 2025 was 45%.
• Total operating expenses decreased by 12% to $13.0 million in 2025 from $14.8 million in 2024.
• The net loss for 2025 was $21.1 million ($2.01 per share), compared to a net loss of $9.0 million ($2.13 per share) in 2024.
• Net cash used in operating activities improved to $9.0 million in 2025 from $10.0 million in 2024.
• The company successfully completed a private placement in October 2025, raising $18.2 million.
• QT Imaging uplisted to The Nasdaq Capital Market in January 2026.
• Exclusive distribution agreements were signed for Saudi Arabia and the UAE.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to significant revenue growth, successful Nasdaq uplisting, and international expansion, despite a continued net loss.

Positives

• Significant revenue growth in 2025, reaching $18.9 million, a 288% increase from $4.9 million in 2024.
• Increased scanner shipments in 2025 to 40 units, up from 12 in 2024.
• Improved operating expense management, with a 12% decrease in total operating expenses for 2025.
• Strengthened financial position through an $18.2 million private placement in October 2025.
• Successful uplisting to The Nasdaq Capital Market in January 2026.
• Expansion into international markets with exclusive distribution agreements in Saudi Arabia and the UAE.

Negatives

• Net loss increased in 2025 to $21.1 million ($2.01 per share) from $9.0 million ($2.13 per share) in 2024.
• The net loss includes significant non-cash expenses and fair value adjustments related to debt and warrants.

Risks

• The proposed amendment to the 2024 Equity Incentive Plan to increase authorized shares could lead to further dilution for existing stockholders.
• The company's financial performance in 2025, while showing revenue growth, still resulted in a net loss.
• The company's ability to attract and retain talent is dependent on equity awards, which can be dilutive.

Future Outlook

The company's equity incentive plan amendment is intended to support retention and talent acquisition, sustain market-competitive compensation, and provide multi-year program stability, anticipating continued growth and revenue increases in 2026 and beyond.

Management Comments

• "We look forward to seeing you at the Annual Meeting."
• "Whether or not you plan to attend the meeting, your vote is very important and we encourage you to vote promptly."

Industry Context

StockSavvy.ai notes that QT Imaging Holdings' focus on expanding its distribution network internationally and uplisting to Nasdaq are common strategies for medical technology companies seeking to scale and increase market visibility.

Management Changes

Corporate Governance

Related Party Transactions

• GigCapital5 issued a Working Capital Note to GigAcquisitions5, which was partially converted into shares and warrants, with the remainder repaid.
• GigAcquisitions5 made an additional loan to GigCapital5 via a Second Non-Convertible Working Capital Note.
• GigCapital5 issued an Extension Note to GigAcquisitions5, which was later exchanged for PIPE Shares and PIPE Warrants.
• QT Imaging, Inc. issued convertible promissory notes and a working capital note to Dr. John Klock, with maturity dates extended.
• The company entered into a Data Use and License Agreement with QT Imaging Center (Dr. Klock's former practice) for de-identified health information.
• The company entered into a Sublease Agreement with QT Imaging Center for office space.
• Dr. Raluca Dinu is married to Dr. Avi S. Katz, Chairman of the Board.

Stakeholder Impact

• Shareholders: The proposed increase in equity incentive plan shares may lead to dilution, but is intended to align interests and attract talent.
• Employees: The equity incentive plan aims to motivate and retain key personnel.
• Directors: The election of directors and their independence are key governance aspects.
• Auditors: Ratification of BPM LLP as auditor ensures continued financial oversight.

Next Steps

• Hold the Annual Meeting of Stockholders on July 28, 2026.
• Seek stockholder approval for the election of directors.
• Seek stockholder approval for the ratification of BPM LLP as independent auditor.
• Seek stockholder approval for the amendment to the 2024 Equity Incentive Plan to increase authorized shares.

Key Dates

Recommendation

While revenue growth and Nasdaq uplisting are positive, the continued net loss and potential dilution from the equity incentive plan warrant a cautious 'hold' recommendation. Further operational improvements and profitability are needed to justify a 'buy'.

Keywords

QT Imaging Holdings, Proxy Statement, Annual Meeting, Election of Directors, Independent Auditor, Equity Incentive Plan, Stockholder Approval, Financial Report, Revenue Growth, Net Loss, Nasdaq Uplisting